Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados Anais da ABC (AABC) (1) BJID (1) Autor Chiari,Brasília M. (1) Correr,Cassyano Januário (1) Goulart,Bárbara N. G. (1) Pontarolo,Roberto (1) Venson,Rafael (1) Wiens,Astrid (1) Mais... Palavra-chave Cost-effectiveness evaluation (2) Chronic (1) Communication disorders (1) Diagnosis of health situation (1) Epidemiologic measurements (1) Epidemiology (1) Hepatitis B (1) Lamivudine (1) Needs assessment (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2011 (1) 2009 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última The role of research methodology in the rational use of technology in monitoring and preventing communication disorders Anais da ABC (AABC) Chiari,Brasília M.; Goulart,Bárbara N. G.. Studies showing stronger scientific evidence related to speech, language and hearing pathology (SLP) have an impact on the prevention and rehabilitation of human communication and gained ground in SLP research agenda. In this paper we discuss some aspects and directions that should be considered for in-depth knowledge about speech, language and hearing needs in different population groups (age group, gender and other variables according to specific related disorders) for improved comprehensive care, successful efforts and effective use of financial and human resources. It is also discussed the decision making process for requesting complementary evaluations and tests, from routine to highly complex ones, that should be based on each test and/or procedure... Tipo: Info:eu-repo/semantics/article Palavras-chave: Communication disorders; Diagnosis of health situation; Epidemiology; Epidemiologic measurements; Needs assessment; Cost-effectiveness evaluation. Ano: 2009 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652009000300014 Cost-effectiveness of telbivudine versus lamivudine for chronic hepatitis B BJID Wiens,Astrid; Venson,Rafael; Correr,Cassyano Januário; Pontarolo,Roberto. BACKGROUND AND AIM: Chronic hepatitis B is a highly prevalent disease worldwide, leading to serious consequences if not properly treated. Six treatment options for chronic hepatitis B are currently provided by the Brazilian public health system. Telbivudine is a nucleoside analogue that is neither included in the Brazilian clinical protocol nor in the therapeutic guidelines for chronic hepatitis B. OBJECTIVE: The aim of this study was to evaluate the cost-effectiveness of telbivudine for the viewpoint of the Brazilian public system, comparing it to lamivudine. METHODS: A Markov model was used to project lifetime complications and costs of treatment with lamivudine or telbivudine for chronic hepatitis B in both HBeAg-positive and HBeAg-negative patients. To... Tipo: Info:eu-repo/semantics/article Palavras-chave: Lamivudine; Cost-effectiveness evaluation; Hepatitis B; Chronic. Ano: 2011 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702011000300008 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco